Mayo Clinic Labs
  • MayoACCESS
  • MayoLINK
  • Register
  • My Dashboard
Test Catalog
  • Algorithms
  • Download Test Catalog & Interpretive Handbook
  • New Tests
  • NY State Informed Consent Tests
  • Performing Locations
  • Referred Tests
  • Specialty Testing
  • Test Updates
Ordering & Results
  • Critical Values & Results
  • Custom Gene Ordering
  • Forms
  • LIS Resources
  • MayoACCESS Resources
  • MayoLINK Resources
  • Order Your First Test
  • Patient Information and Signature Forms
  • Request Additional Testing
  • Send Additional Specimen
Specimen Handling
  • Collection & Preparation
  • Dangerous Goods Training
  • Shipping & Courier Guides
  • Shipping Regulations
  • Supplies
Customer Service
  • Billing
  • Contact Us
  • FAQ
  • IT Updates
  • Operational Updates
  • Quality & Compliance
Education & Insights
  • Educational Resources
  • News
  • Outreach
  • Podcasts
  • Stories
  • Contact
  • Log Out
Insights
  • Education
  • News
  • Podcasting
  • Stories
A Mayo Pathologist’s Journey through Paraneoplastic Syndrome and a Double Lung Transplant: Dr. Brad Karon

After mysterious neurological symptoms began in 2010, Brad Karon, M.D., Ph.D., was diagnosed with paraneoplastic syndrome, a rare condition that led to groundbreaking research and test development at Mayo Clinic. Years later, pulmonary fibrosis and a double lung transplant would test him once again — and redefine his resilience.

July 21, 2025
The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.
August 14, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

Labor Day Specimen Shipping Guidelines and Schedule
August 13, 2025

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming Labor Day holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and international clients.

A simpler path to answers for patients with mast cell activation syndrome
August 11, 2025

A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by detecting key mast cell mediators.

Highlighting Mayo Clinic Laboratories’ innovative approach to autoimmune neurology testing
June 16, 2022

This July, Mayo Clinic’s Neuroimmunology Laboratory will showcase its revolutionary approach to autoimmune neurology testing at the American Academy of Neurology (AAN) Summer Conference: Autoimmune Neurology and Neurology Year in Review in San Francisco. During the meeting, Mayo Clinic Laboratories representatives will highlight our growing list of disease-specific tests and discuss how results can inform decision-making and improve treatment outcomes.

The Age of Pandemics: Dr. Bill Morice
June 16, 2022

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the latest developments in monkeypox, the reality of living in the age of pandemics, and the importance of testing and public-private partnerships.

Mayo Clinic Labs @Work: Shannon Bennett
June 15, 2022

As director of Regulatory Affairs for the Department of Laboratory Medicine and Pathology, Shannon Bennett helps safeguard Mayo Clinic’s reputation for quality care by ensuring that its clinical laboratories operate at the highest level of regulatory compliance.

Whole exome sequencing for hereditary disorders
June 14, 2022

Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small insertions or deletions, and copy number variants on approximately 20,000 genes, enabling precision answers to accurately diagnose, manage, and treat patients with identified inherited illness.

Mayo Clinic Laboratory and pathology research roundup: June 14
June 14, 2022

Featured Abstract: Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.

Independence Day Specimen Shipment Alert
June 11, 2022

Due to the Independence Day holiday, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.

Week in Review: June 10
June 10, 2022

Today's highlights include: Moderna says updated vaccine works better against Omicron, FDA advisors back Novavax COVID shot, and disparities remain in opioid treatment access.

Monkeypox: Dr. Bill Morice
June 9, 2022

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice consider the recent uptick in cases of monkeypox and what labs can do to help facilitate accurate diagnosis of it and other viral infections.

The Living Breast Biobank
June 8, 2022

This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.

Being Mindful of Mental Health: John Black, M.D.
June 7, 2022

John Black, M.D., co-director of the Personalized Genomics Lab at Mayo Clinic, joins the "Answers From the Lab" podcast for a discussion with Bobbi Pritt, M.D., about mental health awareness. In this episode, Dr. Black and Dr. Pritt review key takeaways from Mental Health Awareness Month, the role that lab testing plays in mental health, and the robust science behind treatment.

Mayo Clinic Laboratory and pathology research roundup: June 7
June 7, 2022

Featured abstract: Nuclear GSK-3β and oncogenic KRas lead to the retention of pancreatic ductal progenitor cells phenotypically similar to those seen in IPMN.

Collaboration that changes lives: Elyn Simmons
June 6, 2022

Working together, Mayo Clinic laboratory medicine specialists and clinicians helped Elyn Simmons get her life back — and welcome two new lives to the world.

View MoreView Less
Mayo Clinic Labs
Mayo Clinic Labs
  • Mayo Clinic
  • About us
  • BioPharma
  • Cardiovascular services
  • Newsroom
Resources
  • FAQ
  • Policies
  • Quality
  • Careers
  • Insights
  • Terms of use
  • Privacy statement
Accounts
  • Mayo account
  • MayoLINK
  • Register
  • Dashboard
  • Log out
Contacts
  • Contacts
  • Customer service
Facebook Twitter Instagram LinkedIn YouTube
© 1995–2025 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.